Option Care Health Reports Q1 Results and Lowers Revenue Guidance
Option Care Health reported first-quarter revenue of $1.4 billion (up ~1%) but lowered its full-year net revenue guidance to between $5.675 billion–$5.775 billion due to a reset in the chronic inflammatory disease portfolio, which caused a 600 basis point drag and an expected gross profit headwind of about $55 million. Adjusted EBITDA was $105 million (down 6%) but aligned with expectations.
Tickers: $OPCH
Topics: biosimilars chronic inflammatory disease earnings ebitda eps guidance leveraging revenue share buybacks